DIMENSION CAPITAL II, L.P. purchased 50.0% of their position (1.11M shares) of ODYSSEY THERAPEUTICS, INC. on the open market
Open‑market purchase worth $20.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/12/2026ACC: 0001012975-26-000417
Director
Since May 2026
-13.79M
Net shares
Net seller
$20.00M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
2.82M acquired · 16.61M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.71M
Price / share
—
Trade value
—
% of position
333.3%
5/8/2026
512.86K→2.22M
Common Stock
Direct
Shares
+1.11M
Price / share
$18.00
Trade value
$20M
% of position
50.0%
5/8/2026
2.22M→3.33M
Total
Net shares
+2.82M
Net value
$20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/8/2026 | C · Conversion | +1.71M | — | — | 333.3% | 512.86K | 2.22M |
| Common Stock Direct | 5/8/2026 | P · Purchase | +1.11M | $18.00 | $20M | 50.0% | 2.22M | 3.33M |
| Total | +2.82M | $20M | ||||||
Derivative Transactions1
Series D Convertible Preferred Stock
Direct
Converts to
Common Stock
1.71M shares
Shares
−16.61M
Strike price
Held after
0.00
Exercisable
—
5/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series D Convertible Preferred Stock Direct | Common Stock1.71M shares | 5/8/2026 | C · Conversion | −16.61M | — | 0.00 |